TROXERUTINE MYLAN 3.5 g, powder for oral solution in a single-dose sachet 10 sachets of 7 g
Active ingredients: TROXÉRUTINE
Commercialized according to BDPM
Powder for oral solution10 sachets of 7 gorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TROXERUTINE MYLAN 3,5 g, poudre pour solution buvable en sachet-dose
- Pharmaceutical form
- poudre pour solution buvable
- Route of administration
- orale
- Presentation description
- 10 sachet(s)-dose(s) papier aluminium polyéthylène de 7 g
- Marketing authorisation holder
- MYLAN SAS
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 1 Feb 2022
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64899898CIP73489473CIP133400934894732Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TROXÉRUTINEpoudre | 3,5 g · un sachet dose | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.